Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRAVE: Ranibizumab vs Bevacizumab for RVO Macular Edema
NCT01428388Phase 4Completed
- Sponsor
- Barnes Retina Institute
- Start
- Sep 2011
- Primary completion
- Oct 2015
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of ranibizumab, bevacizumab in macular edema, retinal vein occlusion (RVO), sponsored by Barnes Retina Institute. Started Sep 2011; status: completed.
02
Drugs
ranibizumabbevacizumab
03
Conditions
macular edemaretinal vein occlusion (RVO)
Beyond the preview
Go deeper on NCT01428388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01428388.